Clinical Trial Update: Bryostatin 1 In Treating Patients With Progressive Kidney Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating Bryostatin-1 in patients with progressive kidney cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Bryostatin-1 (bryostatin-1)

Snippet

Sponsor: Cancer Research UK | Conditions: Kidney Cancer | Phase 2 | Status: COMPLETED